Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge (Q48022505)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 January 2018

Language	Label	Description	Also known as
English	Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge	scientific article published on 18 January 2018

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge (English)

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Plasmodium vivax

0 references

1 reference

based on heuristic

inferred from title

François Nosten

9

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Arturo Reyes-Sandoval

15

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

10

object named as

Laurent Rénia

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

author name string

Tarsila Mendes de Camargo

1

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Elisângela Oliveira de Freitas

2

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Alba Marina Gimenez

3

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Luciana Chagas Lima

4

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Karina de Almeida Caramico

5

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Kátia Sanches Françoso

6

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Oscar Bruna-Romero

7

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Chiara Andolina

8

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Hildegund C J Ertl

11

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Ruth S Nussenzweig

12

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Victor Nussenzweig

13

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Mauricio M Rodrigues

14

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Irene S Soares

16

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

language of work or name

0 references

publication date

18 January 2018

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Scientific Reports

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

8

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

1

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

1118

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

copyright license

Creative Commons Attribution 4.0 International

18 January 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a1, MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-γ producing cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

The suitability of laboratory-bred Anopheles cracens for the production of Plasmodium vivax sporozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Vaccines against malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica Serovar Typhimurium flagellin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

CD8+ T effector memory cells protect against liver-stage malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Preclinical Vaccine Study of Plasmodium vivax Circumsporozoite Protein Derived-Synthetic Polypeptides Formulated in Montanide ISA 720 and Montanide ISA 51 Adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Vaccine Adjuvants: Putting Innate Immunity to Work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

New insights on adenovirus as vaccine vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Distribution of Plasmodium vivax variants (VK210, VK247 and P. vivax-like) in three endemic areas of the Amazon region of Brazil and their correlation with chloroquine treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Global occurrence of Plasmodium vivax-like human malaria parasite.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Identification of Plasmodium vivax-like human malaria parasite

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Wide distribution of the variant form of the human malaria parasite Plasmodium vivax

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

22 May 2018

Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

14 August 2018

Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

14 August 2018

TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella Typhimurium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

14 August 2018

New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

14 August 2018

Biophysical characterization of the recombinant merozoite surface protein-3 of Plasmodium vivax.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

14 August 2018

Prevalence and level of antibodies to the circumsporozoite protein of human malaria parasites in five states of the Amazon region of Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

14 August 2018

Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5773670

14 August 2018

Identifiers

10.1038/S41598-017-19063-6

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 February 2018

http://europepmc.org/abstract/PMC/5773670

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48022505&oldid=2209029100"